InsiderTrades

Form 4 for PGNY Progyny, Inc.

Accepted 2024-01-05 00:00:00 ET · period of report 2024-01-02 · accession 0001551306-24-000005 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-01-05 2024-01-02 PGNY Livingston Mark S. CFO S - Sale+OE $36.59 -12.4K 46.9K -21% -$452.5K
D 2024-01-05 2024-01-02 PGNY Livingston Mark S. CFO F - Tax $36.59 -12.6K 59.2K -18% -$462.2K
D 2024-01-05 2024-01-02 PGNY Livingston Mark S. CFO M - OptEx $3.95 +22.0K 71.9K +44% +$86.9K
D 2024-01-05 2024-01-02 PGNY Livingston Mark S. CFO M - OptEx $0.00 -22.0K 64.6K -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-01-02 S D 9,368 $36.52 49,871 D — —
2 Common Common Stock 2024-01-02 F D 12,632 $36.59 59,239 D — —
3 Common Common Stock 2024-01-02 S D 3,000 $36.81 46,871 D — —
4 Common Common Stock 2024-01-02 M A 22,000 $3.95 71,871 D — —
5 Derivative Stock Option (Right to Buy) 2024-01-02 M D 22,000 $0.00 64,627 D $3.95 · — to 2029-06-03 22,000 Common Stock (F2) These options are fully vested and exercisable.